| 股號 / 名稱 | 現金及約當現金 | 流動資產 | 總資產 |
| REPL Replimune Group Inc | 97,672,000.0 | 479,164,000.0 | 532,930,000.0 |
| PLRX Pliant Therapeutics Inc | 114,297,000.0 | 489,898,000.0 | 521,605,000.0 |
| KNSA Kiniksa Pharmaceuticals Ltd | 141,078,000.0 | 270,591,000.0 | 519,673,000.0 |
| TSVT 2Seventy Bio Inc | 56,792,000.0 | 212,842,000.0 | 511,051,000.0 |
| TRDA Entrada Therapeutics Inc | 68,436,000.0 | 414,172,000.0 | 510,844,000.0 |
| RVNC Revance Therapeutics Inc | 132,609,000.0 | 369,686,000.0 | 508,119,000.0 |
| RCKT Rocket Pharmaceuticals Inc | 35,276,000.0 | 345,159,000.0 | 499,442,000.0 |
| MRUS Merus NV | 178,168,000.0 | 410,260,000.0 | 498,083,000.0 |
| CTKB Cytek Biosciences Inc | 167,299,000.0 | 392,060,000.0 | 494,457,000.0 |
| KROS Keros Therapeutics Inc | 442,443,000.0 | 463,126,000.0 | 485,819,000.0 |
| CGEM Cullinan Therapeutics Inc | 98,434,000.0 | 480,191,000.0 | 484,182,000.0 |
| GERN Geron Corp | 189,761,000.0 | 451,509,000.0 | 482,074,000.0 |
| MNKD MannKind Corp | 193,272,000.0 | 383,102,000.0 | 480,879,000.0 |
| KOD Kodiak Sciences Inc | 285,507,000.0 | 289,309,000.0 | 479,372,000.0 |
| COGT Cogent Biosciences Inc | 215,801,000.0 | 441,903,000.0 | 476,111,000.0 |
| VYGR Voyager Therapeutics Inc | 143,078,000.0 | 409,137,000.0 | 469,592,000.0 |
| CSTL Castle Biosciences Inc | 82,949,000.0 | 295,778,000.0 | 458,507,000.0 |
| CDMO Avid Bioservices Inc | 30,708,000.0 | 103,589,000.0 | 455,227,000.0 |
| EDIT Editas Medicine Inc | 69,227,000.0 | 305,555,000.0 | 440,347,000.0 |
| SEER Seer Inc | 54,398,000.0 | 324,150,000.0 | 421,962,000.0 |
| DCPH Deciphera Pharmaceuticals Inc | 91,228,000.0 | 349,937,000.0 | 420,928,000.0 |
| VERA Vera Therapeutics Inc | 69,105,000.0 | 416,370,000.0 | 419,356,000.0 |
| ARCT Arcturus Therapeutics Holdings Inc | 288,396,000.0 | 375,788,000.0 | 418,849,000.0 |
| BHVN Biohaven Ltd | 182,705,000.0 | 348,744,000.0 | 418,532,000.0 |
| LXRX Lexicon Pharmaceuticals Inc | 96,494,000.0 | 364,647,000.0 | 417,219,000.0 |
| SANG Sangoma Technologies Corp | 18,389,000.0 | 61,599,000.0 | 414,075,000.0 |
| CRBU Caribou Biosciences Inc | 49,400,000.0 | 304,514,000.0 | 406,825,000.0 |
| TNGX Tango Therapeutics Inc | 61,163,000.0 | 352,036,000.0 | 406,222,000.0 |
| ANAB AnaptysBio Inc | 53,695,000.0 | 372,420,000.0 | 405,835,000.0 |
| TYRA Tyra Biosciences Inc | 254,366,000.0 | 390,778,000.0 | 404,741,000.0 |
| STRO Sutro Biopharma Inc | 65,218,000.0 | 354,582,000.0 | 403,402,000.0 |
| IBRX Immunitybio Inc | 133,035,000.0 | 195,722,000.0 | 400,679,000.0 |
| CCCC C4 Therapeutics Inc | 89,659,000.0 | 279,592,000.0 | 398,371,000.0 |
| ATXS Astria Therapeutics Inc | 172,012,000.0 | 374,521,000.0 | 378,807,000.0 |
| IGMS IGM Biosciences Inc | 79,173,000.0 | 302,753,000.0 | 376,132,000.0 |
| AUTL Autolus Therapeutics PLC | 239,566,000.0 | 275,302,000.0 | 375,381,000.0 |
| TGTX TG Therapeutics Inc | 75,477,000.0 | 360,581,000.0 | 373,323,000.0 |
| ERAS Erasca Inc | 76,726,000.0 | 306,623,000.0 | 370,022,000.0 |
| VCEL Vericel Corp | 62,938,000.0 | 189,718,000.0 | 356,661,000.0 |
| PHAT Phathom Pharmaceuticals Inc | 322,229,000.0 | 340,314,000.0 | 356,499,000.0 |
| ADMA ADMA Biologics Inc | 45,325,000.0 | 276,419,000.0 | 350,875,000.0 |
| ORIC Oric Pharmaceuticals Inc | 56,360,000.0 | 324,083,000.0 | 350,786,000.0 |
| TARS Tarsus Pharmaceuticals Inc | 193,705,000.0 | 340,724,000.0 | 349,278,000.0 |
| KMDA Kamada Ltd | 48,194,000.0 | 157,808,000.0 | 343,174,000.0 |
| LOGC ContextLogic Inc | 250,000,000.0 | 331,000,000.0 | 342,000,000.0 |
| ARQT Arcutis Biotherapeutics Inc | 88,398,000.0 | 330,431,000.0 | 341,365,000.0 |
| MCRB Seres Therapeutics Inc | 111,184,000.0 | 165,181,000.0 | 341,262,000.0 |
| VTYX Ventyx Biosciences Inc | 141,898,000.0 | 319,759,000.0 | 332,078,000.0 |
| EYPT EyePoint Pharmaceuticals Inc | 271,013,000.0 | 317,709,000.0 | 329,247,000.0 |
| LBPH Longboard Pharmaceuticals Inc | 54,395,000.0 | 323,441,000.0 | 327,665,000.0 |
| DAWN Day One Biopharmaceuticals Inc | 270,391,000.0 | 326,034,000.0 | 326,645,000.0 |
| TIL Instil Bio Inc | 9,195,000.0 | 160,759,000.0 | 325,630,000.0 |
| NRIX Nurix Therapeutics Inc | 49,813,000.0 | 250,969,000.0 | 312,674,000.0 |
| MGTX MeiraGTx Holdings PLC | 119,206,000.0 | 149,300,000.0 | 309,235,000.0 |
| ADCT ADC Therapeutics SA | 234,285,000.0 | 290,206,000.0 | 307,966,000.0 |
| ANNX Annexon Inc | 151,941,000.0 | 270,740,000.0 | 304,069,000.0 |
| ABOS Acumen Pharmaceuticals Inc | 46,930,000.0 | 255,831,000.0 | 300,967,000.0 |
| MGNX MacroGenics Inc | 100,956,000.0 | 251,339,000.0 | 298,418,000.0 |
| VRNA Verona Pharma PLC | 254,882,000.0 | 271,840,000.0 | 289,912,000.0 |
| NAUT Nautilus Biotechnology Inc | 25,729,000.0 | 185,094,000.0 | 288,650,000.0 |
| INBX Inhibrx Inc | 252,483,000.0 | 274,538,000.0 | 288,577,000.0 |
| DSGN Design Therapeutics Inc | 29,397,000.0 | 273,886,000.0 | 278,793,000.0 |
| PSTX Poseida Therapeutics Inc | 44,472,000.0 | 226,475,000.0 | 273,885,000.0 |
| ADVM Adverum Biotechnologies Inc | 149,608,000.0 | 199,130,000.0 | 267,828,000.0 |
| SRRK Scholar Rock Holding Corp | 91,979,000.0 | 246,933,000.0 | 267,285,000.0 |
| GLUE Monte Rosa Therapeutics Inc | 99,752,000.0 | 199,036,000.0 | 266,746,000.0 |
| ANIK Anika Therapeutics Inc | 68,629,000.0 | 158,962,000.0 | 263,744,000.0 |
| OLMA Olema Pharmaceuticals Inc | 33,720,000.0 | 252,090,000.0 | 263,694,000.0 |
| RPTX Repare Therapeutics Inc | 103,217,000.0 | 254,670,000.0 | 263,084,000.0 |
| GOSS Gossamer Bio Inc | 38,863,000.0 | 255,269,000.0 | 259,360,000.0 |
| RYTM Rhythm Pharmaceuticals Inc | 53,428,000.0 | 235,753,000.0 | 258,651,000.0 |
| ADAP Adaptimmune Therapeutics PLC | 140,670,000.0 | 186,903,000.0 | 258,010,000.0 |
| MXCT MaxCyte Inc | 22,249,000.0 | 178,674,000.0 | 257,930,000.0 |
| AGEN Agenus Inc | 52,856,000.0 | 60,352,000.0 | 256,559,000.0 |
| PRAX Praxis Precision Medicines Inc | 151,980,000.0 | 211,804,000.0 | 250,409,000.0 |
| TERN Terns Pharmaceuticals Inc | 65,099,000.0 | 245,895,000.0 | 246,766,000.0 |
| TCRX TScan Therapeutics Inc | 140,513,000.0 | 164,721,000.0 | 240,832,000.0 |
| WVE WAVE Life Sciences Ltd | 180,922,000.0 | 196,767,000.0 | 235,270,000.0 |
| AURA Aura Biosciences Inc | 26,279,000.0 | 212,249,000.0 | 235,025,000.0 |
| FULC Fulcrum Therapeutics Inc | 39,949,000.0 | 217,952,000.0 | 232,588,000.0 |
| PBYI Puma Biotechnology Inc | 84,585,000.0 | 156,185,000.0 | 230,528,000.0 |
| XBIT XBiotech Inc | 201,039,000.0 | 203,056,000.0 | 227,858,000.0 |
| GHRS GH Research PLC | 78,420,000.0 | 164,089,000.0 | 226,300,000.0 |
| MDXG MiMedx Group Inc | 48,487,000.0 | 138,853,000.0 | 221,681,000.0 |
| KZR Kezar Life Sciences Inc | 35,493,000.0 | 206,950,000.0 | 221,235,000.0 |
| XOMA XOMA Corp | 136,225,000.0 | 146,890,000.0 | 219,420,000.0 |
| ABSI Absci Corp | 72,362,000.0 | 120,578,000.0 | 217,298,000.0 |
| ALXO ALX Oncology Holdings Inc | 14,041,000.0 | 167,864,000.0 | 212,650,000.0 |
| ACET Adicet Bio Inc | 159,711,000.0 | 162,272,000.0 | 207,295,000.0 |
| STOK Stoke Therapeutics Inc | 178,581,000.0 | 193,275,000.0 | 205,182,000.0 |
| URGN Urogen Pharma Ltd | 131,439,000.0 | 196,760,000.0 | 200,574,000.0 |
| MRSN Mersana Therapeutics Inc | 75,186,000.0 | 187,538,000.0 | 198,373,000.0 |
| LQDA Liquidia Corp | 157,858,000.0 | 167,936,000.0 | 197,116,000.0 |
| CMRX Chimerix Inc | 19,026,000.0 | 163,032,000.0 | 194,042,000.0 |
| CELC Celcuity Inc | 30,662,770.0 | 190,590,600.0 | 191,219,400.0 |
| AQB AquaBounty Technologies Inc | 8,203,870.0 | 11,637,750.0 | 187,551,430.0 |
| TNYA Tenaya Therapeutics Inc | 59,303,000.0 | 128,699,000.0 | 184,899,000.0 |
| DTIL Precision BioSciences Inc | 137,766,000.0 | 160,828,000.0 | 184,741,000.0 |
| CTMX CytomX Therapeutics Inc | 36,185,000.0 | 167,247,000.0 | 184,687,000.0 |
| OMGA Omega Therapeutics Inc | 60,033,000.0 | 70,890,000.0 | 183,680,000.0 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例